Manulife (Manufacturers Life Insurance)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.2M | Buy |
112,727
+201
| +0.2% | +$25.3K | 0.01% | 707 |
|
2025
Q1 | $12.4M | Buy |
112,526
+2,217
| +2% | +$245K | 0.01% | 749 |
|
2024
Q4 | $15.1M | Sell |
110,309
-6,943
| -6% | -$948K | 0.01% | 714 |
|
2024
Q3 | $13.5M | Sell |
117,252
-8,149
| -6% | -$939K | 0.01% | 758 |
|
2024
Q2 | $17.3M | Buy |
125,401
+1,074
| +0.9% | +$148K | 0.02% | 652 |
|
2024
Q1 | $17.1M | Buy |
124,327
+7,372
| +6% | +$1.02M | 0.02% | 669 |
|
2023
Q4 | $15.4M | Buy |
116,955
+18,070
| +18% | +$2.38M | 0.01% | 697 |
|
2023
Q3 | $11.1M | Buy |
98,885
+4,345
| +5% | +$489K | 0.01% | 764 |
|
2023
Q2 | $8.92M | Sell |
94,540
-3,724
| -4% | -$351K | 0.01% | 838 |
|
2023
Q1 | $9.95M | Sell |
98,264
-2,853
| -3% | -$289K | 0.01% | 801 |
|
2022
Q4 | $12.1M | Sell |
101,117
-1,290
| -1% | -$154K | 0.01% | 733 |
|
2022
Q3 | $10.8M | Buy |
102,407
+728
| +0.7% | +$76.7K | 0.01% | 764 |
|
2022
Q2 | $9.93M | Buy |
101,679
+1,768
| +2% | +$173K | 0.01% | 827 |
|
2022
Q1 | $9.34M | Sell |
99,911
-7,233
| -7% | -$676K | 0.01% | 930 |
|
2021
Q4 | $9.12K | Sell |
107,144
-1,843
| -2% | -$157 | 0.01% | 984 |
|
2021
Q3 | $10.5M | Buy |
108,987
+5,465
| +5% | +$524K | 0.01% | 910 |
|
2021
Q2 | $10.1M | Sell |
103,522
-7,037
| -6% | -$685K | 0.01% | 961 |
|
2021
Q1 | $10.8M | Buy |
+110,559
| New | +$10.8M | 0.01% | 916 |
|
2020
Q3 | – | Sell |
-1,931
| Closed | -$242K | – | 2927 |
|
2020
Q2 | $242K | Buy |
+1,931
| New | +$242K | ﹤0.01% | 2395 |
|
2020
Q1 | – | Sell |
-2,290
| Closed | -$246K | – | 2872 |
|
2019
Q4 | $246K | Sell |
2,290
-85
| -4% | -$9.13K | ﹤0.01% | 2458 |
|
2019
Q3 | $214K | Sell |
2,375
-114
| -5% | -$10.3K | ﹤0.01% | 2540 |
|
2019
Q2 | $210K | Buy |
+2,489
| New | +$210K | ﹤0.01% | 2615 |
|
2018
Q4 | – | Sell |
-2,209
| Closed | -$272K | – | 2716 |
|
2018
Q3 | $272K | Sell |
2,209
-302
| -12% | -$37.2K | ﹤0.01% | 2584 |
|
2018
Q2 | $247K | Sell |
2,511
-13
| -0.5% | -$1.28K | ﹤0.01% | 2951 |
|
2018
Q1 | $209K | Sell |
2,524
-117
| -4% | -$9.69K | ﹤0.01% | 2988 |
|
2017
Q4 | $205K | Sell |
2,641
-75
| -3% | -$5.82K | ﹤0.01% | 2979 |
|
2017
Q3 | $167K | Buy |
2,716
+51
| +2% | +$3.14K | ﹤0.01% | 3118 |
|
2017
Q2 | $123K | Buy |
2,665
+193
| +8% | +$8.91K | ﹤0.01% | 3299 |
|
2017
Q1 | $107K | Sell |
2,472
-18
| -0.7% | -$779 | ﹤0.01% | 3159 |
|
2016
Q4 | $97K | Sell |
2,490
-20
| -0.8% | -$779 | ﹤0.01% | 3236 |
|
2016
Q3 | $127K | Buy |
2,510
+141
| +6% | +$7.13K | ﹤0.01% | 3087 |
|
2016
Q2 | $108K | Sell |
2,369
-123,361
| -98% | -$5.62M | ﹤0.01% | 3184 |
|
2016
Q1 | $4.67M | Buy |
125,730
+810
| +0.6% | +$30.1K | ﹤0.01% | 1072 |
|
2015
Q4 | $7.07K | Sell |
124,920
-7,207
| -5% | -$408 | 0.01% | 848 |
|
2015
Q3 | $5.26K | Buy |
132,127
+78,541
| +147% | +$3.13K | 0.01% | 988 |
|
2015
Q2 | $2.56K | Buy |
53,586
+759
| +1% | +$36 | ﹤0.01% | 1345 |
|
2015
Q1 | $2.1K | Buy |
52,827
+4,863
| +10% | +$193 | ﹤0.01% | 1385 |
|
2014
Q4 | $1.07K | Sell |
47,964
-1,119
| -2% | -$25 | ﹤0.01% | 1544 |
|
2014
Q3 | $770 | Buy |
49,083
+1,041
| +2% | +$16 | ﹤0.01% | 1726 |
|
2014
Q2 | $712K | Sell |
48,042
-2,185
| -4% | -$32.4K | ﹤0.01% | 1803 |
|
2014
Q1 | $808 | Sell |
50,227
-438
| -0.9% | -$7 | ﹤0.01% | 1773 |
|
2013
Q4 | $473 | Sell |
50,665
-1,104
| -2% | -$10 | ﹤0.01% | 2094 |
|
2013
Q3 | $586 | Sell |
51,769
-1,574
| -3% | -$18 | ﹤0.01% | 1894 |
|
2013
Q2 | $714K | Buy |
+53,343
| New | +$714K | ﹤0.01% | 1656 |
|